TTUHSC Excels in National NSF Innovation Corps Teams
With a regional I-Corps Innovation Hub just down the street from TTUHSC's Lubbock campus, there are continuous opportunities for participation from students and faculty within the Texas Tech University System.
Teaching an Old Drug New Tricks
Sanjay Srivastava, Ph.D., earned a U.S. patent for repurposing an antipsychotic drug to treat various types of cancer.
Humanitarian Effort to Eradicate Schistosomiasis Enters Important Stage
Primarily found in sub-Saharan Africa, the Middle East, Southeast Asia and the Caribbean, schistosomiasis is second only to malaria as a deadly tropical parasitic disease.
Uterine Cancer On the Rise Highlighting Drastic Disparities Among Black and Hispanic/LatinX Women
Cancer experts are ringing alarm bells due to the rise in uterine cancer. Numbers of uterine cancer annually are now equal to ovarian cancer.
Snail Fever Vaccine Reaches First Human Clinical Trial
A preventative vaccine for major tropical disease schistosomiasis has reached a Phase 1 clinical trial, providing a dose for the first healthy human volunteer.
Gene Sequencing an Important Tool in COVID-19 Battle
Gene sequencing, a process of determining the sequential order of the building blocks that make up a strand of DNA, is used to keep pace with the constantly moving target that is COVID-19.
TTUHSC Research Receives Prestigious Status as Carnegie Classification® for Special Focus Four-Year Research Institution
The Carnegie Classification® of Institutions of Higher Education has designated Texas Tech University Health Sciences Center (TTUHSC) as a Special Focus Four-Year Research Institution.
TTUHSC’s Reynolds Receives CPRIT Research Grant to Study Childhood Cancers
CPRIT awarded a four-year, $1.34 million grant to C. Patrick Reynolds, M.D., Ph.D., director for the School of Medicine Cancer Center at the Texas Tech University Health Sciences Center.
Bridging Academia and Industry to Advance Drone Technologies
Alongside Texas Tech University and 2THEDGE, a leading technology consulting and investing firm, TTUHSC unveiled the groundwork of a future public-private collaboration supporting the advancement of Unmanned Aerial Systems (UAS) research at a summit event on the TTUHSC campus Wednesday, April 6.
Pharmacy Researchers Receive Patent for Chemical Probe
Nadia German, Ph.D., and collaborator Constantinos Mikelis, Ph.D., have received a U.S. patent for a chemical that targets the brain’s dopamine transporter.
TTUHSC Receives NIH Grant to Examine Impact of Vitamin A Depletion on Alzheimer’s Disease
To gain insight into the potential relationship between ROS accumulation in the dentate gyrus and the onset of Alzheimer’s disease, the National Institutes of Health recently awarded a five-year, $1.87 million grant to TTUHSC's J. Josh Lawrence, Ph.D.
Texas Tech University Health Sciences Center Researchers Achieve Global Recognition
The global preeminence of TTUHSC is highlighted by a widely publicized citation database created at Stanford University. The comprehensive database shows that TTUHSC is the academic home to several of the world’s top-ranked biomedical and pharmaceutical researchers.
TTUHSC’s Rahman Receives Grant Extension
In its most recent funding cycle, the Cancer Prevention & Research Institute of Texas (CPRIT) awarded a $2,499,999 grant extension to Rakhshanda Rahman, M.D., professor of breast surgical oncology at the Texas Tech University Health Sciences Center School of Medicine and the founding executive director of the school’s multi-campus Breast Center of Excellence (BCE).
NIH Awards Grant to TTUHSC Researcher
To better understand the role of extracellular vesicles in the spread and progression of LAM, the NIH recently awarded a four-year, $2.8 million grant to Magdalena Karbowniczek, M.D., Ph.D., a professor of immunotherapeutics and biotechnology at the TTUHSC Jerry H. Hodge School of Pharmacy.
TTUHSC Researchers Receive New NIH Grant to Continue Studying Amygdala-Pain Link
The National Institutes of Health (NIH) recently awarded a five-year, $2.76 million grant to Volker E. Neugebauer, M.D., Ph.D. and Igor Ponomarev, Ph.D.
Possible Societal Gains From Increased Investment in Women’s Health Research
Women’s Health Access Matters (WHAM) is a nonprofit organization dedicated to exploring and responding to the underrepresentation of women in health research, in particular the inequities that exist when it comes to funding dedicated to improving the lives of women.
TTUHSC Researchers Receive Patent for Identifying Viable Embryos
The Texas Tech Office of Research Commercialization (ORC) filed an initial U.S. patent application in 2016, and a patent was awarded to Prien and Penrose on Nov. 8, 2021.
New Research to Examine Effects of Vitamin E on Obesity
Vitamin E has antioxidant properties that protect cells against molecules produced when your body breaks down food. Leslie Shen, Ph.D., C.C.R.P., said these molecules may play a role in other diseases such as obesity.
TTUHSC Researchers to Study Efficacy of Telepractice in Treating Children Born with Cleft Palate
The clinical trial grant, “Speech Intervention via Telepractice for Children with Repaired Cleft Palate: Randomized Controlled Trial and Assessment of Speech Production and Perception Skills,” is the first multi-year NIH grant awarded to the School of Health Professions.
- #Breast Center of Excellence
- #Campus Life
- #F. Marie Hall Institute for Rural and Community Health
- #F. Marie Hall SimLife Center
- #Feature Stories
- #Garrison Institute on Aging
- #Graduate School of Biomedical Sciences
- #Hispanic-Serving Institution
- #Laura W. Bush Institute for Women's Health
- #Mental Health Initiative
- #News Releases
- #Paul L. Foster School of Medicine
- #Permian Basin
- #Public Art
- #School of Health Professions
- #School of Medicine
- #School of Nursing
- #School of Pharmacy
- #School of Population and Public Health
- #Team Member Spotlight
- #Texas Tech Physicians
- #The Free Clinic
- #TTUHSC in the News
- #Well Beyond
- #Women's Health